IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,549,000 | +24.8% | 230,804 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $6,850,000 | -11.8% | 225,106 | -2.8% | 0.00% | 0.0% |
| Q3 2021 | $7,765,000 | -11.6% | 231,506 | +5.1% | 0.00% | -20.0% |
| Q2 2021 | $8,784,000 | -11.9% | 220,212 | -0.7% | 0.01% | -16.7% |
| Q1 2021 | $9,972,000 | -27.1% | 221,801 | -8.3% | 0.01% | -33.3% |
| Q4 2020 | $13,678,000 | +27.9% | 241,920 | +7.4% | 0.01% | +12.5% |
| Q3 2020 | $10,691,000 | -12.4% | 225,318 | +8.8% | 0.01% | -11.1% |
| Q2 2020 | $12,210,000 | +26.1% | 207,091 | +1.1% | 0.01% | 0.0% |
| Q1 2020 | $9,684,000 | -16.8% | 204,824 | +6.3% | 0.01% | +12.5% |
| Q4 2019 | $11,635,000 | -0.1% | 192,596 | -0.9% | 0.01% | -11.1% |
| Q3 2019 | $11,643,000 | +1.1% | 194,341 | +8.5% | 0.01% | -10.0% |
| Q2 2019 | $11,515,000 | -1.5% | 179,168 | +24.4% | 0.01% | 0.0% |
| Q1 2019 | $11,693,000 | +62.4% | 144,057 | +8.2% | 0.01% | +42.9% |
| Q4 2018 | $7,201,000 | +20.8% | 133,197 | +15.3% | 0.01% | +40.0% |
| Q3 2018 | $5,960,000 | +34.1% | 115,554 | +8.4% | 0.01% | +25.0% |
| Q2 2018 | $4,443,000 | -7.0% | 106,630 | -1.6% | 0.00% | -20.0% |
| Q1 2018 | $4,775,000 | -7.0% | 108,325 | +6.2% | 0.01% | 0.0% |
| Q4 2017 | $5,132,000 | +9.7% | 102,036 | +10.6% | 0.01% | 0.0% |
| Q3 2017 | $4,678,000 | -7.0% | 92,272 | -6.7% | 0.01% | -16.7% |
| Q2 2017 | $5,032,000 | +25.4% | 98,914 | -1.0% | 0.01% | 0.0% |
| Q1 2017 | $4,014,000 | -8.9% | 99,863 | +8.4% | 0.01% | 0.0% |
| Q4 2016 | $4,405,000 | -34.0% | 92,087 | -49.5% | 0.01% | -40.0% |
| Q3 2016 | $6,679,000 | +372.3% | 182,288 | +200.2% | 0.01% | +400.0% |
| Q2 2016 | $1,414,000 | -70.7% | 60,726 | -49.0% | 0.00% | -75.0% |
| Q1 2016 | $4,821,000 | +1.3% | 119,049 | +54.9% | 0.01% | 0.0% |
| Q4 2015 | $4,761,000 | – | 76,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |